• 1. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 4. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

Introduction to 3-(aminomethyl)indolin-2-one hydrochloride (CAS No. 1187931-73-2)

3-(aminomethyl)indolin-2-one hydrochloride, with the chemical identifier CAS No. 1187931-73-2, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This compound belongs to the indolinone class, which has garnered considerable attention due to its versatile biological activities and potential therapeutic applications. The hydrochloride salt form enhances its solubility and stability, making it a valuable intermediate in the synthesis of more complex molecules.

The indolinone scaffold is a privileged structure in drug discovery, exhibiting a wide spectrum of pharmacological properties. 3-(aminomethyl)indolin-2-one hydrochloride specifically has been studied for its role in modulating various biological pathways, particularly those involving enzyme inhibition and receptor interaction. Recent advancements in computational chemistry and high-throughput screening have highlighted its potential as a lead compound in the development of novel therapeutic agents.

In the context of modern drug design, the amine and hydroxyl functionalities present in 3-(aminomethyl)indolin-2-one hydrochloride provide multiple sites for chemical modification, enabling the creation of derivatives with enhanced pharmacokinetic profiles. This flexibility has made it a subject of interest for medicinal chemists aiming to develop treatments for diseases such as cancer, inflammation, and neurodegenerative disorders.

One of the most compelling aspects of 3-(aminomethyl)indolin-2-one hydrochloride is its reported activity as an inhibitor of certain kinases and proteases. Kinases play a crucial role in cell signaling pathways, and their dysregulation is often associated with various diseases, including cancer. By targeting these enzymes, 3-(aminomethyl)indolin-2-one hydrochloride has shown promise in preclinical studies as a potential anti-cancer agent. Furthermore, its ability to interact with other cellular targets suggests broader therapeutic possibilities.

Recent research has also explored the compound's interactions with bacterial enzymes, indicating its potential as an antimicrobial agent. The growing threat of antibiotic-resistant bacteria has spurred interest in discovering new compounds that can disrupt bacterial survival mechanisms. 3-(aminomethyl)indolin-2-one hydrochloride's structural features may allow it to interfere with essential bacterial processes, offering a novel approach to combat infections.

The synthesis of 3-(aminomethyl)indolin-2-one hydrochloride involves multi-step organic transformations, typically starting from readily available indole derivatives. The introduction of the amine group at the 3-position and subsequent formation of the hydrochloride salt require precise control over reaction conditions to ensure high yield and purity. Advances in synthetic methodologies have improved the efficiency of these processes, making it more feasible to produce larger quantities for research and development purposes.

From a pharmacological perspective, the solubility profile of 3-(aminomethyl)indolin-2-one hydrochloride is advantageous for formulating drug products. Poor solubility can limit bioavailability and therapeutic efficacy, but the hydrochloride salt form mitigates this issue by enhancing water solubility. This property is particularly important for oral formulations where rapid absorption is desired.

The safety profile of 3-(aminomethyl)indolin-2-one hydrochloride has been evaluated through various in vitro and in vivo studies. These assessments aim to determine its toxicity, immunogenicity, and potential side effects before it can be considered for human trials. Preliminary findings suggest that the compound is well-tolerated at tested doses, although further studies are necessary to fully understand its safety profile.

In conclusion,3-(aminomethyl)indolin-2-one hydrochloride (CAS No. 1187931-73-2) represents a promising candidate for further exploration in pharmaceutical research. Its unique structural features, combined with its reported biological activities, make it a valuable tool for developing new treatments against various diseases. As research continues to uncover more about its properties and potential applications,3-(aminomethyl)indolin-2-one hydrochloride is likely to play an increasingly important role in drug discovery and development pipelines.

• 1504-06-9(3-Methyloxindole)
• 3456-79-9(3-Phenyl-oxindole)
• 19501-89-4(3,3,7-Trimethylindolin-2-one)
• 78610-70-5(2-Oxoindoline-3-carbaldehyde)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)